tiprankstipranks
Serina Therapeutics (SER)
NYSE MKT:SER
Holding SER?
Track your performance easily

Serina Therapeutics (SER) Financial Statements

185 Followers

Serina Therapeutics Financial Overview

Serina Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.941; its P/E ratio is -0.88; Serina Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Jun 23
Income Statement-
Total Revenue$ 14.00K$ 51.00K$ 5.00K$ 56.00K$ 7.00K
Gross Profit$ 14.00K$ 51.00K$ 5.00K$ 55.00K$ 7.00K
EBIT$ -5.31M$ 5.42M$ -9.34M$ -3.47M$ -1.89M
EBITDA$ -5.25M$ 5.48M$ -9.29M$ -3.32M$ -936.00K
Net Income Common Stockholders$ 1.41M$ 5.20M$ -9.44M$ -3.46M$ 808.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.19M$ 6.06M$ 8.71M$ 345.00K$ 261.00K
Total Assets$ 7.43M$ 10.71M$ 10.86M$ 11.96M$ 12.28M
Total Debt$ 11.47M$ 11.71M$ 11.08M$ 4.37M$ 33.01M
Net Debt$ 8.28M$ 5.65M$ 2.38M$ 4.02M$ 32.75M
Total Liabilities$ 21.26M$ 27.10M$ 15.16M$ 6.61M$ 34.34M
Stockholders Equity$ -13.77M$ -16.36M$ -4.31M$ 5.47M$ -22.18M
Cash Flow-
Free Cash Flow$ -2.90M$ -8.00M$ -1.61M$ -2.05M$ -1.18M
Operating Cash Flow$ -2.90M$ -8.00M$ -1.60M$ -2.05M$ -864.00K
Investing Cash Flow$ -3.00K-$ -14.00K-$ -315.00K
Financing Cash Flow$ 86.00K$ 5.37M$ 2.73M$ 2.00M$ -11.00K
Currency in USD

Serina Therapeutics Earnings and Revenue History

Serina Therapeutics Debt to Assets

Serina Therapeutics Cash Flow

Serina Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis